Literature DB >> 380461

Synergistic effects of ampicillin-aminoglycoside combinations on group B streptococci.

M D Cooper, R E Keeney, S F Lyons, E L Cheatle.   

Abstract

The in vitro activity of gentamicin, tobramycin, kanamycin, and amikacin in combination with ampicillin was determined against aminoglycoside-resistant group B streptococci. Synergy in each combination was determined by quantitative kill curves and demonstrated in all the combinations tested.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 380461      PMCID： PMC352690          DOI： 10.1128/AAC.15.3.484

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  5 in total

1.  Synergy of penicillin-netilmicin combinations against enterococci including strains highly resistant to streptomycin or kanamycin.

Authors:  C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

Review 2.  Pharmacological basis for antimicrobial therapy in newborn infants.

Authors:  G H McCracken
Journal:  Am J Dis Child       Date:  1974-09

3.  The spectrum of group B streptococcal infections in infancy.

Authors:  J B Howard; G H McCracken
Journal:  Am J Dis Child       Date:  1974-12

4.  Recurrence of group B streptococcal infection.

Authors:  D D Broughton; W G Mitchell; M Grossman; W K Hadley; M S Cohen
Journal:  J Pediatr       Date:  1976-08       Impact factor: 4.406

5.  Antibiotic-killing kinetics of group B streptococci.

Authors:  V Schauf; A Deveikis; L Riff; A Serota
Journal:  J Pediatr       Date:  1976-08       Impact factor: 4.406
  5 in total
  8 in total

1.  Antimicrobial resistance in colonizing group B Streptococci before the implementation of a Swedish intrapartum antibiotic prophylaxis program.

Authors:  M Granlund; P Axemo; K Bremme; A-L Bryngelsson; M Carlsson Wallin; C-M Ekström; S Håkansson; B Jacobsson; K Källén; E Spetz; I Tessin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-13       Impact factor: 3.267

2.  Group B streptococcal infection in the newborn.

Authors:  M I Marks
Journal:  Can Med Assoc J       Date:  1979-10-20       Impact factor: 8.262

3.  Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci.

Authors:  C N Baker; C Thornsberry; R R Facklam
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

Review 4.  Antibiotics in neonatal infections: a review.

Authors:  V Fanos; A Dall'Agnola
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

5.  High-level chromosomal gentamicin resistance in Streptococcus agalactiae (group B).

Authors:  A Buu-Hoï; C Le Bouguenec; T Horaud
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

6.  Antagonism of ampicillin and chloramphenicol for meningeal isolates of group B streptococci.

Authors:  J L Weeks; E O Mason; C J Baker
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

7.  Is Penicillin Plus Gentamicin Synergistic against Clinical Group B Streptococcus isolates?: An In vitro Study.

Authors:  Corinne Ruppen; Agnese Lupo; Laurent Decosterd; Parham Sendi
Journal:  Front Microbiol       Date:  2016-10-21       Impact factor: 5.640

8.  Is Penicillin Plus Gentamicin Synergistic Against Sessile Group B Streptococcal Isolates? An in Vivo Study With an Experimental Model of Foreign-Body Infection.

Authors:  Corinne Ruppen; Thomas Mercier; Denis Grandgirard; Stephen L Leib; Cristina El Haj; Oscar Murillo; Laurent Decosterd; Parham Sendi
Journal:  Front Microbiol       Date:  2018-05-15       Impact factor: 5.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.